Literature DB >> 20161085

Population Pharmacokinetic/Pharmacodyanamic Mixture Models via Maximum a Posteriori Estimation.

Xiaoning Wang1, Alan Schumitzky, David Z D'Argenio.   

Abstract

Pharmacokinetic/pharmacodynamic phenotypes are identified using nonlinear random effects models with finite mixture structures. A maximum a posteriori probability estimation approach is presented using an EM algorithm with importance sampling. Parameters for the conjugate prior densities can be based on prior studies or set to represent vague knowledge about the model parameters. A detailed simulation study illustrates the feasibility of the approach and evaluates its performance, including selecting the number of mixture components and proper subject classification.

Entities:  

Year:  2009        PMID: 20161085      PMCID: PMC2743512          DOI: 10.1016/j.csda.2009.04.017

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  11 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Bayesian analysis of population PK/PD models: general concepts and software.

Authors:  David J Lunn; Nicky Best; Andrew Thomas; Jon Wakefield; David Spiegelhalter
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

3.  Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysis.

Authors:  Annabelle Lemenuel-Diot; Christian Laveille; Nicolas Frey; Roeline Jochemsen; Alain Mallet
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-12-07       Impact factor: 2.745

4.  Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype.

Authors:  Nitin Kaila; Robert J Straka; Richard C Brundage
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

5.  Averaging, maximum penalized likelihood and Bayesian estimation for improving Gaussian mixture probability density estimates.

Authors:  D Ormoneit; V Tresp
Journal:  IEEE Trans Neural Netw       Date:  1998

6.  Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations.

Authors:  L B Sheiner; H Halkin; C Peck; B Rosenberg; K L Melmon
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

7.  Nonlinear Random Effects Mixture Models: Maximum Likelihood Estimation via the EM Algorithm.

Authors:  Xiaoning Wang; Alan Schumitzky; David Z D'Argenio
Journal:  Comput Stat Data Anal       Date:  2007-08-15       Impact factor: 1.681

8.  Bayesian nonparametric population models: formulation and comparison with likelihood approaches.

Authors:  J Wakefield; S Walker
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

9.  A Bayesian approach to nonlinear random effects models.

Authors:  A Racine-Poon
Journal:  Biometrics       Date:  1985-12       Impact factor: 2.571

10.  Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.

Authors:  G L Rosner; P Müller
Journal:  J Pharmacokinet Biopharm       Date:  1997-04
View more
  1 in total

1.  Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian.

Authors:  Tatiana Tatarinova; Michael Neely; Jay Bartroff; Michael van Guilder; Walter Yamada; David Bayard; Roger Jelliffe; Robert Leary; Alyona Chubatiuk; Alan Schumitzky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-13       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.